Long-Acting β2-Agonists and Risk of Hypertensive Disorders of Pregnancy: A Cohort Study
Conclusions The results of this study provide evidence suggesting the safety of LABAs for the treatment of asthma in pregnancy, in terms of the risks of HDP and preeclampsia/eclampsia.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Canada Health | Corticosteroid Therapy | Databases & Libraries | France Health | Hypertension | Pre-eclampsia | Pregnancy | Statistics | Study | Women